MetaCap

ProKidney (PROK) News

NASDAQ: PROKHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD

1.04-0.02 (-1.89%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

PROK news summary

We found 6 recent headlines mentioning ProKidney (PROK): 2 in the past week and 4 in the past 30 days, most often from GlobeNewswire, Nasdaq. For price context, PROK is down 1.89% at $1.04. The most recent story, "ProKidney Names Farah Ali CMO As Phase 3 Kidney Therapy Trial Advances", was published by Nasdaq on Nov 19, 2026.

Headlines link to the original publishers. MetaCap does not republish third-party articles.

Summary generated from market data by MetaCap's automated system. Methodology

Latest ProKidney headlines

Stocks mentioned alongside PROK

Compare PROK